Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TVRD

+ Watchlist+ Portfolio

Tvardi Therapeutics, Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.01
52-Week Range
$0.77 – $5.69
Market Cap
$13.90M
P/E (TTM)
—
EPS (TTM)
-2.69
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.47
PEG Ratio
—
Return on Equity
-126.19%
Return on Assets
-55.51%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
1.87
Debt/Equity
0.02
Total Debt
$145.00K
Free Cash Flow
$-16.26M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$119.95K

Market Snapshot

About

Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics for autoimmune and inflammatory diseases. The company focuses on targeting immune cell trafficking and activation pathways.